Bone morphogenetic protein gene therapy using a fibrin scaffold for a rabbit spinal-fusion experiment

Neurosurgery

Volumn 58, Issue 2, 2006, Pages 373-379

  Lee, Tao Chen ^a   Ho, Jih Tsun ^a   Hung, Kuo Sheng ^a   Chen, Wu Fu ^a   Chung, Yueh Hua ^a   Yang, Yu Lin ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

Author keywords

Bone morphogenetic protein (BMP); Fibrin gel; Gene therapy; Scaffold; Spinal fusion

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; FIBRIN; GELATIN SPONGE; HERPESVIRUS VECTOR; REAGENT;

ABSORPTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BONE TISSUE; CELL ENCAPSULATION; CELL SUSPENSION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG IMPLANTATION; EXPRESSION VECTOR; FEASIBILITY STUDY; GEL; GENETIC TRANSFECTION; HISTOPATHOLOGY; KIDNEY CELL; LUMBAR SPINE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RAT; SPINE FUSION; SPINE RADIOGRAPHY; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; CELL LINE; FIBRIN; GENE THERAPY; HUMANS; LUMBAR VERTEBRAE; RABBITS; RATS; SPINAL FUSION; TRANSFORMING GROWTH FACTOR BETA;

EID: 32244449372     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000199725.03186.F6     Document Type: Article

References (34)

1. Alden TD, Pittman DD, Beres EJ, Hankins GR, Kallmes DF, Wisotsky BM, Kerns KM, Helm GA: Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy. J Neurosurg Spine 90:109-114, 1999.
2. Bensaid W, Triffitt JT, Blanchat C, Oudina K, Sedel L, Petite H: A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 24:2497-2502, 2003.
3. Blomback B, Carlsson K, Fatah K, Hessel B, Procyk R: Fibrin in human plasma: Gel architectures governed by rate and nature of fibrinogen activation. Thromb Res 75:521-538, 1994.
4. Boden SD, Schimandle JH, Hutton WC: An experimental lumbar intertransverse process spinal fusion model. Radiographic, histologic, and biomechanical healing characteristics. Spine 20:412-420, 1995.
5. Boden SD, Zdeblick TA, Sandhu HS, Heim SE: The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: A preliminary report. Spine 25:376-381, 2000.
6. Chuang LY, Guh JY, Liu SF, Hung MY, Liao TN, Chiang TA, Huang JS, Huang YL, Lin CF, Yang YL: Regulation of type II transforming-growth-factor-beta receptors by protein kinase C iota. Biochem J 375:385-393, 2003.
7. David SM, Gruber HE, Meyer RA Jr, Murakami T, Tabor OB, Howard BA, Wozney JM, Hanley EN Jr: Lumbar spinal fusion using recombinant human bone morphogenetic protein in the canine. A comparison of three dosages and two carriers. Spine 24:1973-1979, 1999.
8. France JC, Norman TL, Santrock RD, McGrath B, Simon BJ: The efficacy of direct current stimulation for lumbar intertransverse process fusions in an animal model. Spine 26:1002-1008, 2001.
9. Glazer PA, Heilmann MR, Lotz JC, Bradford DS: Use of ultrasound in spinal arthrodesis. A rabbit model. Spine 23:1142-1148, 1998.
10. Helm GA, Alden TD, Sheehan JP, Kallmes D: Bone morphogenetic proteins and bone morphogenetic protein gene therapy in neurological surgery: A review. Neurosurgery 46:1213-1222, 2000.
11. Jockenhoevel S, Zund G, Hoerstrup SP, Chalabi K, Sachweh JS, Demircan L, Messmer BJ, Turina M: Fibrin gel - Advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg 19:424-430, 2001.
12. Laursen M, Hoy K, Hansen ES, Gelineck J, Christensen FB, Bunger CE: Recombinant bone morphogenetic protein-7 as an intracorporal bone growth stimulator in unstable thoracolumbar burst fractures in humans: Preliminary results. Eur Spine J 8:485-490, 1999.
13. Leong LM, Brickell PM: Bone morphogenetic protein-4. Int J Biochem Cell Biol 28:1293-1296, 1996.
14. McGrath MH: Peptide growth factors and wound healing. Clin Surg Res 17:421-432, 1990.
15. Martin GJ Jr, Boden SD, Marone MA, Moskovitz PA: Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: Important lessons learned regarding dose, carrier, and safety. J Spinal Disord 12:179-186, 1999.
16. Minamide A, Kawakami M, Hashizume H, Sakata R, Tamaki T: Evaluation of carriers of bone morphogenetic protein for spinal fusion. Spine 26:933-939, 2001.
17. Ochiya T, Nagahara S, Sano A, Itoh H, Terada M: Biomaterials for gene delivery: Atelocollagen-mediated controlled release of molecular medicines. Curr Gene Ther 1:31-52, 2001.
18. Reddi AH: Bone and cartilage differentiation. Curr Opin Genet Dev 4:737-744, 1994.
19. Reddi AH: Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 16:247-252, 1998.
20. Riley EH, Lane JM, Urist MR, Lyons KM, Lieberman JR: Bone morphogenetic protein-2: Biology and applications. Clin Orthop Relat Res 324:39-46, 1996.
21. Sawin PD, Dickman CA, Crawford NR, Melton MS, Bichard WD, Sonntag VK: The effects of dexamethasone on bone fusion in an experimental model of posterolateral lumbar spinal arthrodesis. J Neurosurg Spine 94:76-81, 2001.
22. Schek RM, Hollister SJ, Krebsbach PH: Delivery and protection of adenovirus using biocompatible hydrogels for localized gene therapy. Mol Ther 9:130-138, 2004.
23. Seeherman H, Wozney J, Li R: Bone morphogenetic protein delivery systems. Spine 27:16-23, 2002.
24. Silcox DH 3rd, Boden SD, Schimandle JH, Johnson P, Whitesides TE, Hutton WC: Reversing the inhibitory effect of nicotine on spinal fusion using an osteoinductive protein extract. Spine 23:291-296, 1998.
25. Silcox DH 3rd, Daftasi T, Boden SD, Schimandle JH, Hutton WC, Whitesides TE Jr: The effect of nicotine on spinal fusion. Spine 20:1549-1553, 1995.
26. Simmons CA, Alsberg E, Hsiong S, Kim WJ, Mooney DJ: Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 35:562-569, 2004.
27. Sims CD, Butler PE, Cao YL, Casanova R, Randolph MA, Black A, Vacanti CA, Yaremchuk MJ: Tissue engineered neocartilage using plasma derived polymer substrates and chondrocytes. Plast Reconstr Surg 101:1580-1585, 1998.
28. Tokunaga K, Taniguchi H, Yoda K, Shimizu M, Sakiyama S: Nucleotide sequence of a full-length cDNA for mouse cytoskeletal β-actin mRNA. Nucleic Acids Res 14:28-29, 1986.
29. Vacanti JP, Morse MA, Saltzman WM, Domb AJ, Perez-Atayde A, Langer R: Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg 23:3-9, 1988.
30. Wozney JM: Bone morphogenetic proteins. Prog Growth Factor Res 1:267-280, 1989.
31. Wozney JM: The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 32:160-167, 1992.
32. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA: Novel regulators of bone formation: Molecular clones and activities. Science 242:1528-1534, 1988.
33. Yang C, Hillas PJ, Baez JA, Nokelainen M, Balan J, Tang J, Spiro R, Polarek JW: The application of recombinant human collagen in tissue engineering. Biodrugs 18:103-119, 2004.
34. Yoshida H, Kamiya A: A quicker preparation method for autologous fibrin glue. Biol Pharm Bull 21:1367-1370, 1998.